(S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(p-tolyl)propanoic acid, 98%, 250mg

(S)-4-(6-(3,5-Dimethylisoxazol-4-yl)-1-(1-(pyridin-2-yl)ethyl)-1H-pyrrolo[3,2-b]pyridin-3-yl)benzoic acid, 98.00%, 5mg

8-(1,3,4-OXADIAZOL-2-YL)-2,4-BIS(TRIFLUOROMETHYL)IMIDAZO[1,2-A][1,8]NAPHTHYRIDINE, 90%, 250mg

2-Oxo-6-thiophen-2-yl-4-trifluoromethyl-1,2-dihydropyridine-3-carbonitrile, 97%, 1g

5-Bromo-3-chloro-2-iodobenzonitrile, 95.0%, 1g

Flat flange reaction vial, cylindrical, graduated, with tempering jacket KF connecting piece, DN 60, 250 ml, 90 mm, 1 Piece

Ethyl 3-(3-methoxyphenyl)propanoate, 95+%, 10g

N-(2-Chloropyrimidin-4-yl)-N,2,3-trimethyl-2H-indazol-6-amine, 95.0%, 5g

2-(5-Chloro-1H-benzo[d]imidazol-2-yl)acetic acid, 95.0%, 1g

2-(2-Bromophenyl)-2-methylpropanenitrile, 95.0%, 5g

3-(Bromomethyl)pyridine Hydrobromide>98.0%(T)5g

5-Bromo-6-methylpicolinaldehyde, 95.0%, 1g

5-Bromo-2-chloro-3-methylaniline, 500mg